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Abstract. 
 
The obligate intracellular protozoan 
 
Toxo-
plasma gondii
 
 resides within a specialized parasito-
phorous vacuole (PV), isolated from host vesicular traf-
ﬁc. In this study, the origin of parasite cholesterol was 
investigated. 
 
T
 
.
 
 gondii
 
 cannot synthesize sterols via the 
mevalonate pathway. Host cholesterol biosynthesis re-
mains unchanged after infection and a blockade in host 
de novo sterol biosynthesis does not affect parasite 
growth. However, simultaneous limitation of exoge-
nous and endogenous sources of cholesterol from the 
host cell strongly reduces parasite replication and para-
site growth is stimulated by exogenously supplied cho-
lesterol. Intracellular parasites acquire host cholesterol 
that is endocytosed by the low-density lipoprotein 
(LDL) pathway, a process that is speciﬁcally increased 
in infected cells. Interference with LDL endocytosis, 
with lysosomal degradation of LDL, or with cholesterol 
translocation from lysosomes blocks cholesterol deliv-
ery to the PV and signiﬁcantly reduces parasite replica-
tion. Similarly, incubation of 
 
T
 
.
 
 gondii
 
 in mutant cells 
defective in mobilization of cholesterol from lysosomes 
leads to a decrease of parasite cholesterol content and 
proliferation. This cholesterol trafﬁcking to the PV is 
independent of the pathways involving the host Golgi 
or endoplasmic reticulum. Despite being segregated 
from the endocytic machinery of the host cell, the 
 
T
 
.
 
 
gondii
 
 vacuole actively accumulates LDL-derived cho-
lesterol that has transited through host lysosomes.
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Introduction
 
Upon entering a host cell, many intracellular pathogens
reside within membrane-bound vacuoles. Successful intra-
cellular parasitism is dependent on the pathogen-driven
control of the biogenesis and maturation of the vacuole,
allowing the establishment of a replication-permissive
niche. The obligate intracellular protozoan 
 
Toxoplasma
gondii
 
 resides in a specialized parasitophorous vacuole
(PV)
 
1
 
 that neither acidifies nor fuses with organelles of the
endocytic cascade and exocytic pathway and, as such, is to-
tally isolated from the host cell vesicular transport system
(Jones et al., 1972; Sibley et al., 1985; Joiner et al., 1990;
Mordue et al., 1999). This parasite is auxotrophic for sev-
eral metabolites (see review by Sinai and Joiner, 1997) and
must exchange nutrients across the PV membrane (PVM),
surrounding it to assure its survival and propagation. This
raises the intriguing issue of how nutrients are obtained
from the host cell by 
 
T
 
.
 
 gondii
 
.
Small soluble molecules of 
 
,
 
1,400 D are able to cross
the PVM through functional pores (Schwab et al., 1994).
Although devoid of transmembrane transporter/receptors
of host cell origin (Porchet-Hennere and Torpier, 1983),
the PVM contains numerous secreted parasite proteins
that might be implicated in metabolite transport (Sinai
and Joiner, 1997; Lingelbach and Joiner, 1998). Within the
vacuolar space is a tubulo-reticular network connected to
the PVM, which likely increases the exchange surface be-
tween the host cytoplasm and intravacuolar parasites (Sib-
ley et al., 1995).
Of importance, the PVM of 
 
T
 
.
 
 gondii
 
 is tightly en-
shrouded by host mitochondria and endoplasmic reticu-
lum (ER), the host cell lipid biosynthetic apparatus (Jones
et al., 1972; Melo et al., 1992; Lindsay et al., 1993; Sinai et
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Abbreviations used in this paper:
 
 CO, cholesteryl oleate; HFF, human
foreskin fibroblast; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A;
LDL, low-density lipoprotein; LP, total lipoproteins; LPDS, LP-deficient
serum; NBD-C, 22-(
 
N
 
-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)23,24-
bisnor-5-cholen-3
 
b
 
)-ol; NPC, Niemann-Pick type C; PV, parasitophorous
vacuole; PVM, PV membrane; SRD cells, mutant CHO cells with a sterol
regulatory defective phenotype; SSD cells, mutant CHO cells with a
squalene synthase deficiency; [
 
3
 
H-CO]-LDL, LDL that is labeled with
[
 
3
 
H-CO]; [NBD-C]-LDL, LDL that is labeled with [NBD-C]. 
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al., 1997). This organelle association has been postulated
to play a role in lipid and possibly membrane scavenging
from these host organelles to the intravacuolar parasite at
sites of PVM-organelle association (Sinai et al., 1997). In-
deed, 
 
T
 
.
 
 gondii
 
 seems to be deficient in its ability to syn-
thesize selected phospholipids de novo (Sinai, A.P., K.A.
Joiner, and D.R. Voelker, unpublished observations).
 
Toxoplasma
 
 membranes contain cholesterol based on
both biochemical and morphological criteria (Monteiro
Cintra and de Souza, 1985; Gallois et al., 1988; Foussard et
al., 1991a, 1991b). Cholesterol is concentrated in rhoptries,
apical secretory organelles implicated in the extension of
the PVM during invasion. Indeed, these organelles have a
very high cholesterol/phospholipid molar ratio of 1.5
(Foussard et al., 1991a). In higher eukaryotic cells, choles-
terol homeostasis is finely regulated by transcriptional,
translational, and posttranslational mechanisms (reviewed
in Goldstein and Brown, 1990; Brown and Goldstein,
1999). Cells have a number of options when it comes to the
use of cholesterol for membrane biogenesis or synthesis of
new molecules derived from cholesterol. This latter is syn-
thesized in the ER via the key enzyme of the mevalon-
ate pathway, the 3-hydroxy-3-methylglutaryl coenzyme A
(HMG-CoA) reductase. Newly synthesized cholesterol
is transported rapidly to the caveolae domains of the
plasma membrane from where it constitutively cycles with
the cell interior. Another important source of cholesterol
is plasma low-density lipoprotein particles (LDL) that are
internalized by specific receptors and delivered to late en-
dosomes/lysosomes for hydrolysis. When cholesterol is
effluxed from lysosomes, the bulk of cholesterol is trans-
ported to the plasma membrane probably by a Golgi-
dependent pathway involving caveolae, while a portion is
delivered to the ER by vesicular transport. Deposition of
excess cellular cholesterol in the form of cholesteryl esters
is catalyzed by the resident ER acyl-CoA:cholesterol acyl-
transferase (ACAT), leading to the biogenesis of lipid
droplets (reviewed in Lange and Steck, 1996; Liscum and
Munn, 1999).
Upon infection with 
 
T
 
.
 
 gondii
 
, the mammalian cell ac-
quires a novel dynamic compartment, the PV, which con-
tains live, dividing microorganisms. We have addressed
the following questions, relating to the origin of choles-
terol for the parasite: Can 
 
T
 
.
 
 gondii
 
 synthesize its own cho-
lesterol via the classical mevalonate pathway? Is the PV
accessible to host cell cholesterol? If accessible, is it the
cholesterol synthesized by the host cell or the exogenous
cholesterol delivered by LDL endocytosis that can be
transported into the parasite? If acquired exogenously
from LDL, is cholesterol transported from lysosomes to
the PV by a direct transfer, a Golgi-, or an ER-dependent
pathway? Is the host cell altered in its cholesterol biosyn-
thesis or LDL uptake in response to parasitization? Is the
parasite capable of replication in host cells unable either
to synthesize cholesterol de novo, or to use LDL-delivered
cholesterol, or both?
Although the 
 
Toxoplasma
 
 PV remains segregated from
vesicular trafficking through the endo- and exocytotic
pathways in the host cell, the results presented here dem-
onstrate that this parasite can actively intercept host LDL-
derived cholesterol, in transit from the lysosomes to other
cellular compartments.
 
Materials and Methods
 
Chemicals and Antibody
 
All chemicals were obtained from either Sigma Chemical Co. or Boeh-
ringer Mannheim Biochemicals, unless indicated otherwise. Analytical
grade solvents were used for lipid analysis. The nitrobenzoxadiazole-cho-
lesterol (NBD-C) was obtained from Molecular Probes, Inc. and stored at
 
2
 
20
 
8
 
C as a 10-mg/100-
 
m
 
l solution in dimethylformamide. U18666A was
from Biomol. Compactin was kindly provided by Dr. Akira Endo (Noko
University, Tokyo, Japan). The SDZ 215-918 cyclosporin A analogue was
provided by Sandoz Pharma, Ltd. Radiolabeling reagents, purchased from
Amersham Corp., included [1
 
a
 
,2
 
a
 
(n)-
 
3
 
H]cholesteryl oleate (sp act, 43 Ci/
mmol), 3-hydroxy-3-methyl[3-
 
14
 
C]glutaryl coenzyme A (sp act, 61 mCi/
mmol), RS-[2-
 
14
 
C]mevalonic acid lactone (sp act, 58 mCi/mmol), [5,6-
 
3
 
H]uracil (sp act, 45 Ci/mmol), and [methyl-
 
3
 
H]thymidine (sp act, 6.7 Ci/
mmol). Human [
 
125
 
I]-diferric transferrin was from DuPont NEN Research
Products. The monoclonal anti–low-density lipoprotein receptor antibody
was obtained from Amersham Corp.
 
Preparation of LDL, Lipoprotein-deficient Serum,
LDL Labeled with NBD-C, or with
[
 
3
 
H]cholesteryl oleate–LDL
 
Human LDL (density 1.019–1.063 g/ml) was isolated from fresh plasma
by zonal density gradient ultracentrifugation as described (Poumay and
Ronveaux-Dupal, 1984). Lipoprotein-deficient serum (LPDS) was pre-
pared by ultracentrifugation of fetal bovine serum (Gemini Bio-Products,
Inc.) after the density was increased to 1.215 g/ml with KBr (Havel et al.,
1955). Total lipoproteins (LP) contained in the supernatant were used to
reconstitute LPDS. The fluorescent lipid NBD-C was incorporated into
LDL by mixing 50 
 
m
 
l of the lipid stock solution with 20 ml of filtered fresh
human plasma. After incubation for 16 h at 37
 
8
 
C, LDL was isolated as de-
scribed above. The association of the NBD-C to the LDL fraction was es-
timated by the specific uptake of the fluorescent LDL by microscopy. The
fluorescence observed after uptake of labeled LDL in the presence of a
40-fold excess of nonlabeled LDL was negligible. Radiolabeling of LDL
with [
 
3
 
H]cholesteryl oleate ([
 
3
 
H-CO]) was previously described (Coppens
et al., 1995).
 
Cell Lines and Culture Conditions
 
The cell lines used in this study included: Chinese hamster ovary cells, pri-
mary human foreskin fibroblasts (HFF), and African green monkey
(Vero) cells. Somatic mutants of CHO cells were generous gifts from Drs.
M. Brown, J. Goldstein, and A. Nohturftt of University of Texas S.W.
Medical Center (Dallas, TX): CHO-7 cells (Metherall et al., 1989), UT-1
cells (Luskey et al., 1983), and a sterol regulatory-defective (SRD) mu-
tant, SRD-1 cells (Metherall et al., 1989). Dr. L. Liscum (Tufts University
School of Medicine, Medford, MA) kindly provided the 2-2 mutant (Dahl
et al., 1992, 1993) and Dr. R. Simoni (Stanford University, Stanford, CA)
generously gave a squalene synthase-deficient (SSD) mutant (Bradfute et
al., 1992). All cell lines were grown as monolayers at 37
 
8
 
C in an atmo-
sphere of 5% CO
 
2
 
 in 
 
a
 
-minimum essential medium (prepared at the Me-
dia Core Facility of the Department of Cell Biology, Yale University),
supplemented with 2 mM 
 
L
 
-glutamine and penicillin/streptomycin (100
U/ml per 100 
 
m
 
g/ml). This culture medium also contained variable % (vol/
vol) of either FBS or LPDS that was reconstituted (or not) with LP, as in-
dicated in each experiment. Specific requirements added in media for the
mutants of CHO cells were: 40 
 
m
 
M compactin for the UT-1 cells, 1 
 
m
 
g/ml
of 25-hydroxycholesterol for the SRD-1 cells, 0.2 mg/ml of geneticin for
the SSD cells.
 
Parasite Culture and Purification
 
The RH strain tachyzoite of 
 
Toxoplasma gondii
 
 was used throughout this
study, and was maintained by passage in the peritoneum of Swiss-Webster
mice or by in vitro culture in Vero cells or HFF, as previously described
(Roos et al., 1994). A purification scheme of intracellular parasites based
on density gradient separation using Nycodenz and isopycnic centrifuga-
tion was developed. Confluent HFF or CHO cell monolayers were in-
fected with 
 
T
 
.
 
 gondii
 
, which were further harvested from the culture su-
pernatants. After two passages through a 27-gauge needle to disrupt any
contaminating host cells, parasites were washed three times in PBS (137
mM NaCl, 2.7 mM KCl, 10 mM NaH
 
2
 
PO
 
4
 
, 1.8 mM KH
 
2
 
PO
 
4
 
, adjusted to 
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pH 7.4) by centrifugation at 1,000 
 
g
 
 in a GRP tabletop centrifuge (Beck-
man Instruments, Inc.) for 10 min. Parasites were then resuspended in
10% Nycodenz before application at the top of a linear Nycodenz gradient
from 30 to 10%. After centrifugation in a swing-out rotor at 2,000 
 
g
 
 for 30
min at room temperature, fractions were collected and analyzed for den-
sity and protein content. Fractions containing parasites were equilibrated
at a density of 1.09–1.11 g/ml of Nycodenz. They were then diluted 2.5-
fold with PBS, centrifuged at 5,000 
 
g
 
 for 30 min, and washed three times in
PBS before use for lipid extraction. The purity of the parasite preparation
was monitored by the comparison of the protein content in the 1.09–1.11-
g/ml fractions after inoculation of the same number of parasites in either
one or three dishes of cell monolayers. When parasites were purified from
three dishes, no increase in protein concentration was observed in the par-
asite fractions, as compared with parasites from one dish.
 
Determination of Parasite Concentration, Replication, 
and Viability 
 
Parasite concentration was determined by numeration using a Hausser
counting chamber at 400
 
3
 
 magnification. The analysis of the number of
parasites per vacuole to estimate the parasite replication and the measure-
ment of [
 
3
 
H]uracil incorporated into the parasites to evaluate their viabil-
ity were determined as previously described (Nakaar et al., 1999). Parasite
cultures were synchronized by removal of parasites that had not yet in-
vaded 4 h after their inoculation into confluent cells.
 
Ligand Radiolabeling and Uptake Experiments 
 
LDL was radiolabeled with 
 
125
 
I by means of ICl (McFarlane, 1958) and
specific radioactivity of 
 
125
 
I-LDL was 300–550 cpm/ng protein. 
 
125
 
I-trans-
ferrin was used at a specific radioactivity of 100–200 cpm/ng protein. For
uptake experiments, confluent cultures of CHO cells in a six-well plate
were inoculated with 10
 
6
 
 freshly lysed-out parasites and incubated for 4 h
at 37
 
8
 
C before washing and resuspension in culture medium containing ei-
ther 10% LPDS (for LDL uptake experiments) or 10% FBS (for transfer-
rin and horseradish peroxidase uptake experiments). The presence or ab-
sence of LP during the 24-h incubation is without influence on the
subsequent transferrin or HRP uptake. 24 h post-infection, cultures were
washed twice with PBS, incubated at 37
 
8
 
C for 2 h in culture medium (de-
void of serum) containing 1% of serum albumin and different concentra-
tions of 
 
125
 
I-LDL, 
 
125
 
I-transferrin, or HRP, and then chilled to 4
 
8
 
C and
washed twice in PBS plus 5% FBS. Cell monolayers were further incu-
bated for 60 min at 4
 
8
 
C in the presence of 0.1% pronase (wt/vol) to re-
move cell surface–bound ligand, washed twice in PBS and lysed in 0.01%
Triton X-100. The pronase-resistant fraction was considered as internal-
ized ligand. For comparison, noninfected CHO cells were used as controls,
and processed identically. Cell-internalized radioiodinated ligand in the
lysate was evaluated in a liquid scintillation system (LS 6000SC; Beckman
Instruments, Inc.) and cell-internalized HRP was determined by measure-
ment of the peroxidase activity in the lysate by the stopped colorimetric
assay using ortho-phenylenediamine as a substrate, according to Steinman
et al. (1976). Values of cell-internalized ligand in infected and uninfected
cells were normalized to total cell protein.
 
Incubation of Infected Cells with [
 
3
 
H-CO]-LDL and 
Lipid Analysis 
 
Synchronized infected cells were incubated in culture medium containing
10% FBS or 10% LPDS. After 24 h, cells were treated with the indicated
inhibitor, and then pulse-labeled with 5 mg of [
 
3
 
H-CO]-LDL. After wash-
ing, parasites were isolated, their protein concentration determined, and
lipids extracted to quantify the amount of [
 
3
 
H-C] associated with the ste-
rol fraction, as described (Coppens et al., 1995). Results were calculated as
counts per minute per milligram cell protein, and then expressed in per-
cent control values corresponding to the amount of [
 
3
 
H-C] associated with
the sterol fraction of infected cells that were incubated in the absence of
any inhibitor.
 
Incubation of Infected Cells with LDL Labeled with 
NBD-C, Filipin, Lipid Droplet Dyes, and
Fluorescence Microscopy 
 
To visualize fluorescent cholesterol associated with 
 
T
 
.
 
 gondii
 
, synchro-
nized infected cells were seeded on coverslips in a 24-well plate and incu-
bated in culture medium containing 10% LPDS. After 24 h, cells were
 
treated with the indicated inhibitor, and then labeled with 0.1 mg of
[NBC-C]-LDL for various pulse-chase times. Coverslips with live cells
were directly observed with an epifluorescence microscope (Microphot
FXA; Nikon Inc.). Images were captured with a CCD camera (Photomet-
rics), processed with Image-Pro Plus (Media Cybernetics), and their con-
trast was enhanced with Adobe Photoshop 5.0 (Adobe Systems Inc.).
For cytochemical staining of 
 
b
 
-hydroxysterols with filipin, infected cells
seeded on coverslips were incubated in culture medium containing 10%
FBS, washed in PBS, and then fixed in 3% paraformaldehyde for 30 min
at room temperature and washed again with PBS. Coverslips with fixed
cells were incubated with 25 
 
m
 
g/ml of filipin for 15 min, washed in PBS,
and mounted with glycerol to be viewed by a fluorescence microscope us-
ing an excitation filter of 350–410 nm. For detection of parasite lipid drop-
lets, extracellular 
 
T
 
.
 
 gondii
 
 from cell cultures incubated in culture medium
plus 10% FBS or 10% LPDS were fixed in paraformaldehyde and stained
with either Oil Red O or Nile Red before observation by phase-contrast
and fluorescence microscopy, as described (Greenspan et al., 1985; El-
Jack et al., 1999).
 
Assay for HMG-CoA Reductase Activity
 
Confluent cultures of CHO cells in 10-cm plates were inoculated with 10
 
7
 
freshly lysed-out parasites and incubated for 4 h at 37
 
8
 
C before washing
and resuspension in culture medium containing either 10% FBS or 10%
LPDS. After 24 h of infection, the activity of HMG-CoA reductase was
measured in situ on digitonin-permeabilized cells using [
 
14
 
C]HMG-CoA
as substrate, as described (Leonard and Chen, 1987; Geelen et al., 1991).
In parallel, noninfected CHO cells were used as controls and similarly
processed. Reductase activity was expressed as picomoles of radioactive
HMG-CoA converted to radioactive mevalonate per minute per milli-
gram detergent-solubilized protein.
 
Mevalonate and HMG-CoA Incorporation into Sterols 
 
To study the biosynthesis of sterols in 
 
T
 
.
 
 gondii
 
, 500 nmol of [
 
14
 
C]meva-
lonic acid or 300 nmol [
 
14
 
C]HMG-CoA was added for 3 h at 37
 
8
 
C to con-
fluent cultures of CHO cells in 10-cm plates infected with 10
 
7
 
 freshly ly-
sed-out parasites for 24 h in medium containing 10% LPDS. For labeling
with HMG-CoA, infected cells were previously permeabilized with digito-
nin (Leonard and Chen, 1987). After washing, parasites were isolated,
their protein concentration determined, and lipids extracted to quantify
the amount of [
 
14
 
C]cholesterol associated with the sterol fraction, as de-
scribed (Coppens et al., 1995). An assay of radioactive mevalonate or
HMG-CoA incorporation was performed on extracellular 
 
T
 
.
 
 gondii
 
 in
conditions where parasites are metabolically active, as described previ-
ously (Coppens et al., 1999).
 
Protein Determination
 
Protein content was determined by the bicinchoninic acid assay (Smith et
al., 1985), using serum albumin as standard.
 
Statistical Analysis 
 
For comparison of means,
 
 P 
 
was determined by analysis of variance
against control (ANOVA 2).
 
Results
 
Cholesterol Is Not Uniformly Distributed
within T. gondii
 
The polyene antibiotic filipin was used to visualize the dis-
tribution of cholesterol or other 
 
b
 
-hydroxy-sterols by light
fluorescence microscopy. In the presence of extracellular
lipoproteins, uninfected fibroblasts showed a filipin-cho-
lesterol staining in the plasma membrane and in intracellu-
lar perinuclear organelles (Fig. 1 A) that have been identi-
fied as lysosomes, endocytic recycling compartments, and
Golgi structures (Butler et al., 1992; Neufeld et al., 1996;
Mukherjee et al., 1998). Cholesterol distribution in para-
sites inside fibroblasts was observed as intense and pre- 
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dominantly located in the plasma membrane and the api-
cal region, including the specialized secretory rhoptries
(Fig. 1 B). This is in accordance with the unusually high
cholesterol/phospholipid molar ratio of these organelles
(Foussard et al., 1991a). No prominent filipin staining was
noted in the PVM, leading to the suggestion that this
membrane, if accessible to filipin, is low in cholesterol
compared with plasma membranes. In parasites dividing
by endodyogeny, filipin stained the nascent apical com-
plexes of the two progenies as well as the residual body,
which is the site of accumulation of structures remaining
from the parent cell (Fig. 1 C).
 
Parasites Are Deficient in their Ability to Synthesize 
Sterols via
 
 
 
the Mevalonate
 
 
 
Pathway
 
To determine whether intracellular parasites are able to
synthesize cholesterol, infected cells were incubated with
radioactive precursors of the mevalonate pathway. Very
low amounts of radioactivity were detected in the parasite
sterol faction compared with CHO cells after incubation
either in the presence of [
 
14
 
C]mevalonate or [
 
14
 
C]HMG-
CoA (Table I). To circumvent a problem of substrate ac-
cessibility, parasite sterols were isolated from extracellular
 
T
 
.
 
 gondii
 
 incubated in the presence of the same radioac-
tive precursors and no radioactivity was found after sterol
isolation (not shown).
Using as host cells the UT-1 mutant, a clone of CHO
cells resistant to the HMG-CoA reductase inhibitor com-
pactin (mol wt 390.5), we demonstrated that parasite repli-
cation was not affected in the presence of 40 
 
m
 
M compac-
tin (not shown), suggesting that this enzyme, if present in
the parasite, is not necessary for parasite growth. These
data indicate that intra- or extracellular parasites do not
synthesize and are not dependent upon de novo sterols via
the classical mevalonate pathway.
 
Host Cholesterol Biosynthesis Remains Unchanged in 
Infected Cells
 
To assess the influence of parasites on host cholesterol
production, we monitored the formation of mevalonate
from [
 
14
 
C]HMG-CoA in parasitized or uninfected cells af-
ter permeabilization with digitonin. As illustrated in Table
II, a similar activity of HMG-CoA reductase was observed
in control cells or in cells containing tachyzoites. The main
contribution of the mevalonate production is from the
host cells since parasites fail to use precursors from the
mevalonate pathway, as demonstrated above in Table I.
The removal of LP from the culture medium induces an
increase of the enzyme activity to the same extent in both
conditions (Table II).
 
Deficiency in Host Cell De Novo Biosynthesis Does Not 
Limit Parasite Growth
 
We have further explored whether parasite replication is
totally independent of host cholesterol biosynthesis, using
as host cells mutants that are defective for cholesterol bio-
Figure 1. Intracellular distribution of cholesterol in uninfected
and T. gondii–infected fibroblasts. Uninfected fibroblasts (A) or
infected with T. gondii (B, arrow) were cultivated for 24 h in me-
dium containing 10% FCS, fixed, cytochemically stained with fil-
ipin for cholesterol detection, and observed by fluorescence mi-
croscopy. In B, the arrowhead shows the location of the PVM.
Alternatively, freshly lysed-out and dividing parasites (C) were
similarly processed for filipin-cholesterol labeling. In C, the ar-
rows indicate the nascent apical complexes of the two progenies
and the arrowhead, the residual body of the parent cell.
 
Table I. Absence of Incorporation of Mevalonate and
HMG-CoA in the Sterol Fraction of T. gondii
 
Incorporation into the sterol fraction of:
Mevalonate HMG-CoA
 
cpm/mg cell protein
 
T. gondii
 
130 
 
6
 
 35 88 
 
6
 
 7
CHO cells 455,150 
 
6
 
 49,800 3,670 
 
6
 
 230
 
Infected or uninfected CHO cells grown for 24 h in medium containing 10% LPDS
were incubated with [14C]mevalonate or [14C]HMG-CoA. After washing, the sterol
fractions of parasites or CHO cells were isolated to determine the radioactivity content.
Values are means 6 SD of three separate experiments.
Table II. Comparison of HMG-CoA Reductase Activity in 
Untreated or Infected Cells by T. gondii
Infected CHO cells Uninfected CHO cells
pmol mevalonate/min per mg cell protein
3.5% LPDS 1 LP 13.5 6 2.6 15.9 6 4.1
3.5% LPDS 29 6 7.4 27.1 6 6.3
CHO cells were grown for 24 h in medium containing LP (or not) in the presence or
absence of parasites. After washing, cells were permeabilized and incubated in the
assay medium containing [14C]HMG-CoA for 30 min at 378C. The reductase activity
was determined by measurement of the production of radioactive mevalonate. Values
are means 6 SD of three separate experiments.Coppens et al. Cholesterol Transport in Toxoplasma gondii–infected Cells 171
synthesis and, therefore, auxotrophic for LDL-derived
cholesterol.
The SSD mutant has a metabolic block at squalene syn-
thase, converting farnesylpyrophosphate to squalene, the
first enzymatic step committed solely to the biosynthesis
of sterols, and is therefore incapable of endogenous cho-
lesterol biosynthesis (Bradfute et al., 1992). As deter-
mined by enumeration of parasites per vacuole, T. gondii
developed normally in SSD cells compared with CHO
cells in medium containing 10% FBS (Fig. 2 A). The levels
of uracil incorporation into newly synthesized parasite nu-
cleic acids (99 6 4% as control of uracil incorporated in
parasites) as well as the filipin-cholesterol staining of these
parasites maintained in these two types of cells were also
similar (not shown). This suggests that host cholesterol
production has no significant effect on parasite replication
and that the bulk of the parasite cholesterol requirement
can be satisfied by exogenous cholesterol.
Blockade of both Exogenous and Endogenous Sources 
of Host Cholesterol Strongly Reduces
Parasite Replication
To determine whether the parasites are still capable of
surviving and multiplying in the absence of any sources of
cholesterol originating from the host cell, we infected the
SSD mutant in medium containing 10% LPDS and moni-
tored parasite viability over a period of 72 h. Assayed by
thymidine incorporation, the SSD mutant can be main-
tained in a medium devoid of extracellular LP for a maxi-
mal time of 12 h (not shown). To avoid effects of host cell
viability loss on parasite replication, we used a serial pas-
sage protocol. Each 12 h after infection, intracellular para-
sites were mechanically harvested from the SSD cells, pu-
rified, and a portion was used for uracil incorporation.
Another portion was used to infect fresh SSD cells (me-
chanically released parasites are fully invasive) at the be-
ginning of their starvation cycle in LPDS. Prolonged time
in the absence of host exogenous and endogenous sources
of cholesterol, achieved by this serial passage protocol, led
to a progressive reduction of parasite replication (Fig. 2
B). Parasite growth was not totally abrogated after 60 h of
LP starvation and beyond, since 30% of the parasite popu-
lation was still detectable. This decrease in replication rate
was reversible since the addition of extracellular LP re-
stored the parasite growth to normal values (not shown).
Extracellular LDL and Exogenous Free Cholesterol 
Stimulate Parasite Growth
We next asked whether parasite growth can be directly de-
pendent upon exogenously supplied cholesterol. The repli-
cation rate of intracellular parasites incubated in culture
medium devoid of LP or with an excess of exogenous cho-
lesterol, either freely administrated or associated with
LDL, was analyzed. Removal of any lipoproteins from the
incubation medium resulted in a reduced incorporation of
[3H]uracil into parasites by 10 and 16%, after 24 and 48 h,
respectively, as compared with incubation in the presence
of 10% FBS (Fig. 3 A). These lower values of radioactive
uracil incorporation were coincident with the presence of
smaller vacuoles containing fewer parasites when parasites
were maintained without LP (Fig. 3 B). This slowing in
parasite multiplication also caused a delay in the parasite-
induced lysis of the monolayer of host cells as monitored
by an increase in the parasite doubling time (10–13 h in
LPDS vs. 6–8 h in FBS).
The cell line CHO-7, a derivative clone of CHO cells se-
lected for growth in lipoprotein-deficient serum (Mether-
all et al., 1989), was used as the host cell for T. gondii.
Figure 2. Parasite replication in the SSD mutant in the presence or absence of LP. (A) The distribution of PV sizes expressed in percent
was determined at 48 and 60 h after infection of the SSD mutant or CHO cells with parasites in the presence 10% FBS in the culture
medium. Data represent the averages for at least 50 randomly selected vacuoles in two different experiments. (B) At 12, 24, 48, 60, and
72 h, corresponding to incubation times of intracellular parasites in the presence or absence of LP, uracil incorporation was assayed us-
ing the SSD mutant infected every 12 h, as described in Materials and Methods. Results are expressed in counts per minute of [3H]uracil
incorporated into parasites per milligram cell protein and are means of two separate experiments done in duplicate.The Journal of Cell Biology, Volume 149, 2000 172
When T. gondii infected CHO-7 cells in medium contain-
ing 10% LPDS, a decrease of parasite growth was ob-
served (85 6 5% of uracil incorporation after 24 h), as
compared with infection of CHO-7 cells in medium con-
taining LP. In addition, filipin staining of the parasite
plasma membrane inside CHO-7 cells was notably less
than when incubated with LP and was not concentrated at
the apical complex as compared with parasites grown in
CHO cells in the presence of 10% FBS (Fig. 3 C). By com-
parison, the intensity of the plasma membrane labeling of
the CHO-7 cells was unchanged in the absence of extracel-
lular LP.
The addition of exogenous cholesterol, particularly when
incorporated into LDL in the incubation medium, has a
stimulatory effect on T. gondii replication, measured by
uracil incorporation into parasites (Fig. 3 D), as well as
enumeration of parasites per PV in infected cells (Fig. 3
E). This growth stimulation was proportional to the con-
centration of LDL in the medium.
Altogether, these data indicate that an exogenous source
of cholesterol, mainly provided by LDL, is required for
optimal intracellular replication of T. gondii, although it is
not essential for growth.
Receptor-mediated Endocytosis of LDL Is Specifically 
Increased in Infected Cells
To assess whether the presence of replicating tachyzoites
in CHO cells resulted from an increased uptake of extra-
cellular LDL as a source of cholesterol for the parasites,
infected and noninfected cells were incubated in parallel
with 125I-LDL, and the extent of radioactive ligand uptake
was determined. Internalization of LDL was stimulated by
two- to threefold in a ligand dose-dependent manner in in-
fected CHO cells (Fig. 4). This uptake was specific for
LDL as internalization of this ligand was inhibitable by an
excess concentration of nonlabeled LDL, indicating that
the enhanced endocytosis of LDL in infected cells did not
result from receptor-independent fluid-phase endocytosis
(not shown). Furthermore, the increased LDL uptake in
infected cells was not a consequence of a global stimu-
lation of endocytosis since uptake of transferrin as an-
other receptor-internalized ligand, or the fluid-phase
tracer HRP was unchanged after infection (Fig. 4).
LDL-derived Cholesterol Is Rapidly Delivered to the PV 
and Is Concentrated in the Parasite
To determine whether intravacuolar parasites can take up
sterols directly from the external medium, we incubated
infected and uninfected fibroblasts with fluorescent NBD-C
incorporated into LDL at 378C. Noninfected cells exposed
to [NBD-C]-LDL exhibited shortly after endocytosis a
pattern of punctate fluorescence consistent with endocytic
structures. After a lag time of z10 min, [NBD-C]-LDL is
degraded to free NBD-C in lysosomal compartments,
which subsequently is transferred to the plasma mem-
brane via the Golgi apparatus (Craig et al., 1981; Ohashi et
al., 1992; Fig. 5 D). Cholesterol that has reached the
plasma membrane is then slowly transferred to cholesterol
acceptors in the surrounding medium (serum proteins),
contributing to a gradual loss of NBD-C, as shown by a de-
Figure 3. Influence of exogenous cholesterol and lipoproteins on
parasite proliferation. (A) Uracil incorporation was assayed us-
ing CHO cells infected for 24 or 48 h in medium containing 10%
LPDS, supplemented (or not) with LP. Data in percent are ex-
pressed relative to control (incubation in the presence of LP)
taken as 100% 6 SEM from four separate experiments done in
triplicate. Differences between values of control and experimen-
tal groups were statistically significant (*P , 0.01). (B) The dis-
tribution of PV sizes expressed in percent was determined at 48
and 60 h after infection of HFF with parasites in 10% LPDS in
the presence or absence of LP. Data represent the averages for at
least 50 randomly selected vacuoles in four different experi-
ments. (C) The CHO and CHO-7 cells infected with parasites
(arrows) were cultivated for 24 h in medium containing 10% FCS
or 10% LPDS, respectively, fixed, cytochemically stained with fil-
ipin for cholesterol detection, and observed by fluorescence mi-
croscopy. (D) Uracil incorporation was assayed using CHO cells
infected for 24 h in medium containing 10% LPDS (solid bars),
or supplemented with 10 mg/ml of water-soluble cholesterol
(chol), or with LDL at the indicated concentrations. Data in per-
cent are expressed relative to control (incubation in the presence
of LPDS) taken as 100% 6 SEM from three separate experi-
ments done in duplicate. Differences between values of control
and experimental groups were statistically significant (*P , 0.01;
**P , 0.005). (E) The percent distribution of PV sizes was deter-
mined at 24 h after infection of HFF with parasites in medium
containing 10% LPDS, supplemented or not with LDL at the in-
dicated concentrations. Data represent the averages for at least
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crease of the plasma membrane signal (Ohashi et al.,
1992).
Short pulses of infected cells with fluorescent LDL led
to a gradual labeling of the PVM, followed by labeling of
intravacuolar parasites (Fig. 5, A–C). Within the parasite,
the labeling corresponding presumably to NBD-C was not
evenly distributed, but was concentrated in the plasma
membrane, the anterior region, and in compact spherical
structures (one to four per parasite) throughout the cyto-
plasm. These latter were identified as lipid droplets (Speer
et al., 1998), based on their specific accumulation of Oil
Red O or Nile Red dyes (not shown). Interestingly, the
number of lipid droplets was reduced in tachyzoites grown
in LPDS-cultured cells as compared with parasites origi-
nating from cells cultivated with extracellular excess LDL
(not shown).
A pulse (1 h)–chase (9 h) experiment performed on in-
fected cells revealed a maintenance of fluorescence associ-
ated with the parasite plasma membrane, the apical struc-
tures, and the lipid droplets (Fig. 5 E); the intensity was
slightly decreased due to a dilution of the NBD-C, con-
comitant with parasite division, while a diffuse labeling
was observed throughout the host cell. The fluorescence
initially associated with the PVM gradually disappeared
with the chase time.
No specific fluorescence was detectable in infected cells
Figure 4. Comparison of receptor-mediated endocytosis and pi-
nocytosis in uninfected and T. gondii–infected fibroblasts. Unin-
fected CHO cells (d) or infected with T. gondii (s) for 24 h were
then incubated at 378C in the presence of the indicated concen-
tration of 125I-LDL, 125I-transferrin, or HRP for 2 h. After wash-
ing, the amount of cell-associated ligand was determined by ra-
dioactivity or enzymatic activity measurement and expressed
as nanograms of ligand per milligram cell protein. Values are
means 6 SD of three separate experiments.
Figure 5. Kinetics of [NBD-C]-LDL acquisition in uninfected or
T. gondii–infected cells. 24 h after infection in medium contain-
ing 10% LPDS, infected fibroblasts were pulse-labeled at 378C
with 0.1 mg/ml of [NBD-C]-LDL for 7 min (A), 12 min (B; fluo-
rescent PVM is indicated by the arrow), or 60 min (C). Cells were
washed and processed for fluorescence observation. In parallel,
noninfected fibroblasts were labeled for 60 min with the fluores-
cent lipoproteins and treated under the same conditions (D). In
one experiment, infected fibroblasts were pulse-labeled at 378C
with 0.1 mg/ml of [NBD-C]-LDL for 60 min, and then chased for
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or in parasites when incubated in medium containing 10%
LPDS and NBD-C administrated as lipid alone, indicating
a requirement for LDL in the acquisition of NBD-C by in-
tracellular T. gondii (not shown).
LDL-derived Cholesterol Acquisition Requires Live 
Intracellular Parasites
The above data demonstrated that the PVs containing T.
gondii gain access to exogenous NBD-C associated with
LDL. To investigate whether this cholesterol uptake is in-
duced by the parasite itself or resulted from a passive
transfer to the PV, we infected cells for 24 h, treated
for the next 20 h with the anti–Toxoplasma drug py-
rimethamine, and then incubated with [NBD-C]-LDL.
The reduction of parasite viability was confirmed by mea-
surement of uracil incorporation, revealing ,10 and
,1% incorporation, compared with control without pyri-
methamine, after exposure to 1 and 10 mM of drug, re-
spectively. The fluorescent labeling in T. gondii was abro-
gated by pyrimethamine treatment in a dose-dependent
manner.
The SDZ 215-918 cyclosporin A derivative is a particu-
larly potent and rapid inhibitor of T. gondii invasion and
replication (Silverman et al., 1997). Incubation of infected
cells with SDZ 215-918 in conditions that inhibit the meta-
bolic activity of intracellular parasites, before exposure to
[NBD-C]-LDL, led to a decrease of fluorescence associ-
ated with the PV (not shown). This indicates that active
parasite metabolism is necessary for cholesterol uptake
(Fig. 6, A–C).
No parasite-associated fluorescence was observed in
preparations of live extracellular tachyzoites exposed to
[NBD-C]-LDL (Fig. 6 D), indicating that parasites are un-
able to internalize these lipoproteins when outside the
host cell and that they acquire cholesterol only after it is
liberated from LDL by host lysosomes. Parasite sequestra-
tion of NBD-C is therefore specific for intracellular T.
gondii.
Inhibitors of the LDL Endocytic Pathway Block 
Cholesterol Transport to the Parasite
We next wanted to elucidate whether delivery of exoge-
nous cholesterol to the parasite involves the endocytic
pathway of the host cell. The transport of LDL-derived
cholesterol from the external medium was measured in the
presence of agents known to block steps in LDL-choles-
terol transport in mammalian cells. These treatments tar-
get LDL internalization and degradation, as well as cho-
lesterol egress from lysosomes, by both vesicular and
nonvesicular transport. Since the viability of parasites is
required for cholesterol uptake, we monitored the levels
of uracil incorporated into the parasites for each inhibitor
tested, and found incorporation of $94% of control with-
out inhibitor.
Preincubation of infected cells with anti–LDL receptor
antibodies inhibited LDL binding to the host cell and ab-
rogated by 90% of control the delivery of radioactive cho-
lesteryl esters to parasites after [3H-CO]-LDL endocytosis
(Table III). This inhibition of accessibility of exogenous
cholesterol by anti–LDL receptor antibodies was con-
firmed by the absence of fluorescent labeling in the host
cell and in intravacuolar parasites after short pulse-label-
ing with [NBD-C]-LDL (Fig. 7, A and B).
The effects of the lysosomotropic agent chloroquine
that impairs acid hydrolase activities (de Duve et al., 1974;
Brown et al., 1975; de Duve, 1983) or of the indigestible
solute sucrose that interferes with the fusion competence
of mature lysosomes (Montgomery et al., 1991) on choles-
terol acquisition by T. gondii, were investigated. In their
presence, the inhibition of tritiated cholesteryl oleate (Ta-
ble III) or fluorescent cholesterol (Fig. 7, C–E) transport
was obvious. At 100 mM chloroquine, LDL degradation
was partial, as shown by a slight fluorescent staining of cel-
lular compartments and parasites, whereas at 200 mM the
drug caused an extensive vacuolization of lysosomes (and
acidic endosomes) leading to a complete blockade of LDL
proteolysis and an absence of release of cholesterol
trapped within the particles. Under these conditions, in-
fected cells showed a bright punctate fluorescent pattern
Figure 6. Absence of [NBD-C]-LDL acquisition in pyri-
methamine-treated or extracellular parasites. 24 h after infec-
tion in medium containing 10% LPDS, infected fibroblasts were
preincubated for 20 h without (A) or with pyrimethamine at 1
(B) or 10 (C) mM. As observed in B9 and C9, the pyrimethamine-
treated cells contain vacuoles with dying or dead parasites (ar-
rows), having abnormal shapes. Cells were then pulse-labeled at
378C with 0.1 mg/ml [NBD-C]-LDL for 60 min, washed, and pro-
cessed for fluorescence observation. Extracellular tachyzoites
were pulse-labeled at 378C with 0.1 mg/ml of [NBD-C]-LDL for
60 min, washed, and directly observed by fluorescence micros-
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(Fig. 7 E), corresponding to lysosomal structures retaining
intact [NBC-C]-LDL, and no fluorescence was observed
elsewhere in infected cells, including the parasite vacuole.
We next tested the influence of U18666A, one of a num-
ber of hydrophobic amines that are reported to induce an
accumulation of free exogenous cholesterol in late endo-
somes/lysosomes during the endocytic processing of LDL
(Roff et al., 1991; Liscum and Faust, 1983; Kobayashi et
al., 1999). Progesterone also sequesters cholesterol in lyso-
somes by an unknown and reversible mechanism (Butler
et al., 1992). Progesterone and U18666A inhibited the
transfer of tritiated cholesteryl oleate into the parasite ste-
rol fractions after endocytosis of the reconstituted radioac-
tive LDL (Table III); moreover, the effects of U18666A
and progesterone are cumulative. This inhibition is coinci-
dent with a weak fluorescent pattern of parasites preincu-
bated with these drugs, alone or in combination, followed
by exposure to [NBD-C]-LDL (Fig. 8). After a 24-h chase
in a progesterone-free medium, the free cholesterol pool
leaves lysosomes to be redistributed intracellularly, as
demonstrated by fluorescence throughout the host cell
and parasites (Fig. 8, B and C).
Agents that disrupt the cytoskeletal network, cytochala-
sin B or colchicine, caused noticeable cell rounding but no
inhibition of LDL-derived cholesterol delivery to intravac-
uolar parasites (Table III). This result demonstrates that
no vesicular transport is involved in cholesterol traffic
from the lysosomes to the ER, and then to the PV, sug-
gesting a route independent of the ER.
Brefeldin A affecting the Golgi apparatus organization
(Misumi et al., 1986; Klausner et al., 1992; Torii et al.,
1995) had no significant effect on cholesterol transport to
T. gondii, suggesting the use of a Golgi-independent path-
way (Table III).
Parasite Replication Is Reduced in a Host Cell Line 
with Defective Mobilization of Cholesterol
from Lysosomes
The cellular and biochemical consequences of the proges-
terone-induced block in lysosomal cholesterol transport
strongly resemble the phenotypic manifestations of the Nie-
mann-Pick type C (NPC) mutation (Pentchev et al., 1986;
Table III. Effect of Treatments on the Acquisition of
[3H-CO]-LDL by Intracellular T. gondii
[3H-C] associated with parasites
Control 100
Blockade of LDL receptors
Anti–LDL receptor antibodies 10 6 4
Defective lysosomal function
Chloroquine 10 6 6
Sucrose 17 6 7
Lysosomal cholesterol sequestration
U18666A 28 6 11
Progesterone 23 6 8
U18666A 1 progesterone 15 6 7
Cytoskeletal disorganization
Cytochalasin B 101 6 21
Colchicine 99 6 8
Disruption of the Golgi
Brefeldin A 93 6 7
[3H-C] uptake by intracellular parasites was determined 24 h after infection using 5 mg/
ml [3H-CO]-LDL for 1 h. This LDL pulse-labeling followed inhibitor treatment of the
infected monolayers, except for cytoskeleton inhibitor conditions, where a 10-min
pulse preceded the drug incubation. Infected cells were washed after each treatment
(except for lysosomal function inhibition and Golgi disruption) before purification of
parasites and the determination of the levels of [3H-C] in the parasite sterol fraction.
Data are expressed in percent relative to control (infected cells without treatment),
taken as 100% 6 SD from three separate experiments done in duplicate. The specific
inhibitor treatments used were: 400 mg/ml anti–LDL receptor antibodies for 1 h at
378C, for 30 min at 48C; 300 mm chloroquine for 15 min; 20 mg/ml sucrose for 2 h; 1
mg/ml U18666A for 90 min; 10 mg/ml progesterone for 24 h; 50 mm cytochalasin B
for 30 min; 50 mm colchicine for 30 min; 1 mg/ml Brefeldin A for 90 min.
Figure 7. Blockade of [NBD-C]-LDL acquisition by parasites
with anti–LDL receptor antibodies or chloroquine. 24 h after in-
fection in medium containing 10% FBS, fibroblasts infected by T.
gondii were preincubated without (A) or with (B) 400 mg/ml
anti–LDL receptor antibodies for 1 h at 378C, and then for 30 min
at 48C, washed, pulse-labeled at 378C for 10 min with 0.1 mg/ml
[NBD-C]-LDL, washed, and processed for fluorescence observa-
tion. In another set of experiments, 24 h after infection in me-
dium containing 10% LPDS, infected fibroblasts were incubated
without drug (C) or with chloroquine either at 100 mM for 150
min (D) or at 200 mM for 30 min (E), pulse-labeled at 378C for 30
min with 0.1 mg/ml of [NBD-C]-LDL, washed, and processed for
fluorescence observation. Vacuoles containing parasites are illus-
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Sokol et al., 1988; Liscum et al., 1989). NPC fibroblasts ex-
hibit lysosomal storage of unesterified cholesterol due to a
single gene defect that affects the egress of LDL-choles-
terol from late endosomes/lysosomes and LDL-mediated
regulation of cellular cholesterol homeostasis (reviewed in
Liscum and Klansek, 1998). The somatic 2-2 mutant de-
rived from CHO cells has the same biochemical pheno-
type of the NPC mutation (Dahl et al., 1992, 1993).
A direct comparison of lysosomal cholesterol processing
and transport to the parasite was carried out between the
2-2 mutant and progesterone-treated cells. Parasite growth
in the 2-2 mutant is reduced by z15 and 25% in compari-
son with control after 24 and 48 h, respectively, as assessed
by uracil incorporation (Fig. 9 A). Concomitant with the
impaired parasite replication in these mutant cells, the
parasite cholesterol content revealed by filipin is weak, in-
dicating a lower cholesterol content due to the retention of
cholesterol inside host lysosomes (compare Fig. 9 B with
Figs. 1 B and 3 C for CHO cells). In addition, incubation of
infected 2-2 mutant cells with [3H-CO]-LDL led to a lower
incorporation of radioactive cholesteryl oleate into para-
sites (64 6 6% of control). Incubation of fibroblasts with
progesterone induced a more drastic decrease of parasite
replication of z50 and 70% after 24 and 48 h, respectively
(Fig. 9 C), as compared with untreated cells, probably con-
sistent with a more profound block in cholesterol delivery
to intracellular parasites (see Table III).
A Large Excess of Host Cholesterol Does Not Modify 
Parasite Growth
The SRD-1 mutant has an increase of cholesterol input
from exogenous LDL and endogenous synthesis due to
the loss of suppression of the sterol-regulated genes in re-
sponse to sterol overload. This mutant also has a stimula-
tion of cholesterol esterification upon addition of 25-
hydroxycholesterol (Metherall et al., 1989). In medium
containing 5% LPDS, the intravacuolar development of
parasites within the SRD-1 mutant is comparable with that
of parasites infecting CHO cells without LP (uracil incor-
poration: 101 6 3% of control). The higher number of
LDL receptors exposed at the surface of the SRD-1 mu-
tant did not increase the amount of tritiated cholesteryl
oleate associated with the parasite sterol fraction after en-
docytosis of [3H-CO]-LDL, representing 96 6 4% of the
parasite control in CHO cells. This suggests that the ability
to acquire exogenous cholesterol by T. gondii might be a
saturable process.
Discussion
The obligate intracellular T. gondii replicates inside a non-
fusogenic vacuole within nucleated cells. The membrane
of the vacuole forms a barrier between the nutrient rich
cytosol and the parasite surface, and prevents access of
host proteins to the vacuole space. The intravacuolar
space is likely full of low molecular weight compounds
originating from the host cell since the PVM contains
pores facilitating passive transfer of molecules (Schwab et
al., 1994). The current data dramatically illustrate a new
feature regarding nutrient acquisition by T. gondii, dem-
onstrating that the parasite can efficiently access choles-
terol from host lysosomal compartments by an active
mechanism, which is independent of vesicular fusion, and
requires parasite viability.
The putative pathway underlying cholesterol-derived
LDL acquisition by T. gondii is the pathway IIIa depicted
in the schematic model in Fig. 10. First, a large contribu-
tion of the receptor-mediated endocytosis of LDL appears
to be the primary mechanism as antibodies against LDL
receptors can block the accessibility of LDL to intracellu-
lar compartments, including Toxoplasma vacuoles (Fig.
10, 1).
Uptake of LDL by host cells infected by T. gondii occurs
Figure 8. Blockade and reversibility of [NBD-C]-LDL acquisi-
tion by parasites with progesterone and U18666A. 24 h after in-
fection in medium containing 10% LPDS, fibroblasts infected by
T. gondii (arrows) were preincubated without drug (A), with
progesterone at 10 mg/ml for 24 h (B and C), with U18666A at 1
mg/ml for 90 min (D), or with progesterone at 10 mg/ml for 20 h,
and then with U18666A at 0.1 mg/ml for 90 min. After washing,
cells were pulse-labeled at 378C for 10 min with 0.1 mg/ml of
[NBD-C]-LDL, washed, and processed for fluorescence observa-
tion. A chase of 24 h in medium containing 10% LPDS was per-
formed in the experiment in C before analysis of the fluorescence
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in an enhanced fashion over uninfected cells. Results do
not distinguish, however, whether this phenomenon is di-
rectly induced by intravacuolar parasites or is a more gen-
eral response of the host cell as a consequence of parasiti-
zation. Since endocytosis of other ligands is not modified
after infection, the putative mechanism may involve a
higher density of cell-surface molecules or receptors capa-
ble of internalizing lipoproteins. If upregulation of the
classical apoprotein B/E LDL receptor is occurring in the
presence of unchanged HMG-CoA reductase activity
upon infection with T. gondii (Table II), this would sug-
gest an unusual pathway of cholesterol regulation (Gold-
stein and Brown, 1990). For another intravacuolar patho-
gen, exposure of macrophages to Chlamydia pneumoniae
specifically increases the LDL uptake and foam cell for-
mation by accumulation of cholesteryl ester droplets by a
mechanism not involving the apoprotein B/E LDL recep-
tor (Kalayoglu et al., 1999).
Endocytosed lipoproteins are delivered to endosomes
and their protein/phospholipid coat degraded in late endo-
somes/lysosomes, yielding free cholesteryl esters that will
be hydrolyzed to cholesterol. In the presence of chloro-
quine or sucrose impairing lysosomal function and pro-
voking an accumulation of intact LDL, minimal molecules
of cholesterol reach the PV, implicating host LDL proteol-
ysis in the parasite acquisition of this lipid (Fig. 10, 2). In-
cubation of T. gondii in host cells where cholesterol trans-
location from late endosomes/lysosomes (2-2 mutant or
treated with progesterone and U18666A) is impaired leads
to a dramatic reduction of cholesterol associated with the
parasites, concomitant with a slowing of parasite replica-
tion (Fig. 10, 3). The higher inhibition of parasite growth
by progesterone compared with the 2-2 mutant might be
related to a direct toxic effect of the steroid on T. gondii.
Alternatively, progesterone is known to sequester in lyso-
somes cholesterol derived not only directly from endocy-
tosed LDL, but also from other existing sterol pools, such
as lipid droplets or organelle membranes (McGookey and
Anderson, 1983; Butler et al., 1992), and could therefore
also remove cholesterol from PV-containing parasites.
In mammalian cells, the mechanisms and precise routes
of transport of cholesterol from late endosomes/lysosomes
to the other cellular compartments are areas of intense in-
vestigation. From the cell biological point of view, the
Toxoplasma vacuole may be considered as such a com-
partment in the infected cell and it could be used as a tool
for analysis of intracellular cholesterol movement in mam-
malian cells. A portion of cholesterol is mobilized to the
plasma membrane through the Golgi apparatus (reviewed
in Liscum and Munn, 1999). The pathway of cholesterol
acquisition by T. gondii is clearly not altered by incubation
of infected cells with Brefeldin A (no use of the pathway
IIIb in Fig. 10), indicating a Golgi-independent route de-
spite the location of mature PVs adjacent to the host cell
Golgi. This absence of delivery of host lipids from the
Golgi to the Toxoplasma vacuole, a matter of some con-
troversy (Melo and de Souza, 1996), has been recently
confirmed by the observation of PV free of fluorescent lip-
ids in experiments using NDB-ceramide loaded in fibro-
blasts before infection with parasites (Mordue et al., 1999).
By comparison, the pathogen Chlamydia trachomatis,
which similarly resides in a nonfusogenic vacuole, inter-
Figure 9. Reduction of parasite
replication and cholesterol con-
tent in the 2-2 mutant or in fibro-
blasts treated with progesterone.
(A) Uracil incorporation was as-
sayed using the 2-2 mutant or
CHO cells as control infected for
24 or 48 h in medium containing
10% FBS. Data in percent are
expressed relative to control
taken as 100% 6 SEM from
three separate experiments done
in duplicate.  Differences be-
tween values of control and ex-
perimental groups were statisti-
cally significant (*P , 0.005).
(B) The 2-2 mutant cells infected
with parasites (arrows) were cul-
tivated for 24 h in medium con-
taining 10% FCS, fixed, cy-
tochemically stained with filipin
for cholesterol detection, and
observed by fluorescence mi-
croscopy. (C) Uracil incorpora-
tion was assayed using fibro-
blasts infected for 24 or 48 h in
medium containing 10% FBS
plus 10 mg/ml of progesterone.
Data in percent are expressed relative to control (infected fibroblasts without progesterone) taken as 100% 6 SEM from three separate
experiments done in duplicate. Differences between values of control and experimental groups were statistically significant (**P ,
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sects with vesicles from the exocytic pathway since this
bacteria can acquire endogenously synthesized sphingo-
myelin in transit from the host Golgi to the plasma mem-
brane (Hackstadt et al., 1995, 1996).
In mammalian cells, a portion of cholesterol effluxed
from lysosomes is delivered to the ER by a pathway that is
independent of the plasma membrane. For this vesicular
transport of cholesterol, actin filaments, but not microtu-
bules, appear to play a role. Cytochalasin B does not alter
the cholesterol movement to the PV, suggesting that cho-
lesterol originating from endocytosed LDL does not tran-
sit through the host ER to reach the Toxoplasma vacuole
(no use of the pathway IIIc in Fig. 10). This observation
suggests that the PVM-host ER association seen in in-
fected cells (Jones et al., 1972; Melo et al., 1992; Sinai et
al., 1997), does not participate in exogenous cholesterol
trafficking, at least when LP are present.
Exogenous cholesterol, associated with LDL or freely
administrated to cells infected by T. gondii, stimulates par-
asite growth and, in the case of large excess, induces the
formation of parasite lipid droplets. Parasites incubated in
the SRD-1 mutant, characterized by a high level of choles-
terol due to a defect in sterol regulation, have a replication
rate comparable with parasites grown in the parental
CHO cell. Parasites do not take up cholesteryl esters pack-
aged into LDL more avidly in spite of a high number of
LDL receptors exposed at the cell surface of the SRD-1
mutant, suggestive of parasite regulatory mechanisms for
sterol homeostasis. These mutant cells also show a high
acyl-CoA:cholesterol acyltransferase activity that does not
influence parasite growth. This is of interest since host es-
terification of cholesterol may be involved in the replica-
tion of T. gondii (Ernst et al., 1999).
Intracellular T. gondii do not modify the rate of host de
Figure 10. Hypothetical pathway for cholesterol acquisition from endocytosed LDL by intracellular T. gondii. This figure depicts the
potential source of cholesterol for intracellular T. gondii after the binding and endocytosis of LDL via specific receptors as well as the
trafficking of cholesterol effluxed from lysosomes to the PV containing four parasites. This pathway III can be blocked at several steps:
(1) anti–LDL receptor antibodies block binding to LDL receptors, (2) chloroquine and sucrose affect the lysosomal function, abolishing
LDL proteolysis, and (3) progesterone, U18666A, and NPC mutation impair cholesterol translocation from late endosomes/lysosomes,
sequestering cholesterol inside these organelles. When blocked, the pathways II in the presence of LP, IIIb, and IIIc have no effect on
T. gondii replication or cholesterol transport to intravacuolar parasites. The absence of host endo- and lysosomal markers detectable
within the PV at any stage during infection excludes a direct access of host intravesicular LDL to the vacuole (pathway IV). No direct
experimental evidence is yet available to support parasite cholesterol biosynthesis (pathway I). C, cholesterol; CE, cholesteryl ester;
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novo cholesterol biosynthesis. Parasites are capable of
replicating in cells altered in their sterol production such
as the SSD mutant. These data indicate that parasites are
not dependent upon host endogenous cholesterol as long
as exogenous sterols are available. They do not intercept
the transport of this lipid from the ER in transit to the
plasma membrane. These results corroborate the absence
of labeled cholesterol associated with the sterol fraction of
parasites after incubation of infected cells with radioactive
precursors of the mevalonate pathway (no use of the path-
way II in Fig. 10). The survival of 30% of the parasite pop-
ulation in the SSD mutant in the absence of LP opens the
question on the origin of other potential sources of sterols
for T. gondii, such as cholesterol from cell debris, stored
cholesteryl esters, probably present in their lipid droplets,
or cholesterol biosynthesized by the parasite. However,
the compactin insensitivity, as well as the absence of sterol
synthesis from precursors of the mevalonate pathway in
the parasites, suggests the absence of the classical meva-
lonate pathway functional for isoprenoid biosynthesis in T.
gondii, as observed for Plasmodium falciparum, an api-
complexan parasite related to T. gondii. An alternative
nonmevalonate pathway for the early steps in the biosyn-
thesis of isoprenoids, the 1-deoxy-D-xylulose 5-phosphate
(DOXP) pathway, has been proposed in the plasmodial
apicoplast, a plastid acquired by members of the phylum
Apicomplexa by secondary endosymbiosis of an alga
(Jomaa et al., 1999; McFadden and Roos, 1999). However,
two lines of evidence suggest that sterol synthesis in the T.
gondii apicoplast is not necessary for parasite replication
in the presence of lipoproteins. First, parasites that cannot
partition the apicoplast to daughter cells replicate nor-
mally in the primary vacuole (D. Roos, personal commu-
nication). Second, inhibitors of the DOXP pathway, which
block plasmodial replication, do not inhibit T. gondii
growth in presence of serum (D. Soldati, personal commu-
nication).
The accumulation of cholesterol from host lysosomes in-
side intravacuolar parasites suggests a largely unidirec-
tional influx of this lipid and may be correlated to the
rapid division rates of T. gondii. Alternatively, the isola-
tion of the PV from the external medium results in the ab-
sence of transfer of cholesterol to extracellular cholesterol
acceptors. The cholesterol transport pathway in cells in-
fected with T. gondii clearly differs from those for the
other cell organelles and is characterized by an absence of
interaction with vesicles involved in export from the Golgi
and ER, as well as those implicated in exchanges between
the plasma membrane and the cell interior. The route of
delivery of exogenous cholesterol from lysosomes to the
PV might involve a sterol-binding protein, mediating a
molecular transport of cholesterol towards the PVM. T.
gondii may actively either divert a host sterol-carrier pro-
tein or synthesize such a protein since parasite viability is
required for cholesterol acquisition. After crossing the
PVM, cholesterol molecules must be translocated to the
parasite. The elucidation of the mechanisms of these two
sequential steps by generation of resistant mutants forms
the basis for our future experiments.
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